About Nymak Pharma
Nymak Pharma is a Healthcare company. Pharmaceutical manufacturing and supply of IV fluids, formulations, and medical devices in global markets. Its Indian entity Nymak Pharma Private Limited reported revenue of ₹5.73 Cr. Nymak Pharma offers products and services including IV Fluids and Medical Devices. Its focus areas include Medical Devices, Disposables and Diagnostics, Rapid Diagnostic Kits and Pharmaceuticals.
Company details
Nymak Pharma was established in 1998 with a focus on producing Sterilized Water for Injections, initially serving regions in the South Pacific. Over time, its operations have expanded to include IV Fluids, Finished Formulations, Medical Devices, Rapid Diagnostic Kits, and Vaccines, reaching 24 countries through consistent quality and adherence to GMP standards. Trust has been built via certifications like ISO 13485, reflecting a commitment to healthcare innovation. The companys facilities are located in Gujarat, India, where products are developed to address global health needs without deviation from ethical practices.
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website nymakpharma.com
- Social LinkedIn Instagram
- Legal Name Nymak Pharma Pvt. Ltd
- Date of Incorporation 23 Sep, 2014
- Jurisdiction Gandhidham, Gujarat, India
- Indian entity revenue₹5.73 Cr
FY 2025
- Indian entity net profit₹13.4 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹35.1 Lakh
FY 2025 · 6% margin
Associated legal entities of Nymak Pharma
Nymak Pharma operates through Nymak Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nymak Pharma Private Limited CIN U33110GJ2014PTC080874 | Active | 23 Sep 2014 | Mundra, Gujarat | ₹5.7 Cr | 3 | View details |
Products & Services of Nymak Pharma
Nymak Pharma offers a comprehensive portfolio of products and services, including IV Fluids and Medical Devices.
IV Fluids are produced and supplied for medical applications, focusing on quality and safety in healthcare settings
Medical Devices and disposables are manufactured and distributed to meet diagnostic and treatment needs across various regions
Board of directors of Nymak Pharma Private Limited (Nymak Pharma)
Nymak Pharma Private Limited is the primary company behind Nymak Pharma. The board of Nymak Pharma Private Limited currently have 3 directors; the longest-serving is Ranjit Sundersing Advani, appointed in 2014. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Ranjit Sundersing Advani DIN 06693793 | Director | 23 Sep 2014 | 12 yrs 1 mo | Nymak Pharma Private Limited |
| Deepa Haresh Advani DIN 06693798 | Director | 23 Sep 2014 | 12 yrs 1 mo | Nymak Pharma Private Limited |
| Haresh Ranjit Advani DIN 06693788 | Director | 23 Sep 2014 | 12 yrs 1 mo | Nymak Pharma Private Limited |
Financials of Nymak Pharma
Figures of Nymak Pharma Private Limited, the primary company behind Nymak Pharma, for FY 2025. Revenue was ₹5.73 Cr. Net profit was ₹13.4 Lakh (2% margin). EBITDA was ₹35.1 Lakh (6% margin).
- ₹5.73 CrRevenue · FY 2025
- ₹13.4 LakhNet profit · 2% margin
- ₹35.1 LakhEBITDA · 6% margin
- ₹50 LakhPaid-up capital
Balance sheet, profit and loss, cash flow and ratios of Nymak Pharma Private Limited are on its company page.
Detailed financial statements for Nymak Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nymak Pharma
The primary company behind Nymak Pharma, Nymak Pharma Private Limited, reported revenue of ₹5.73 Cr for FY 2025.
Nymak Pharma was established in 1998 with a focus on producing Sterilized Water for Injections, initially serving regions in the South Pacific. Over time, its operations have expanded to include IV Fluids, Finished Formulations, Medical Devices, Rapid Diagnostic Kits, and Vaccines, reaching 24 countries through consistent quality and adherence to GMP standards. Trust has been built via certifications like ISO 13485, reflecting a commitment to healthcare innovation. The companys facilities are located in Gujarat, India, where products are developed to address global health needs without deviation from ethical practices.
Nymak Pharma offers IV Fluids and Medical Devices.
Nymak Pharma operates through Nymak Pharma Private Limited.
The legal entities of Nymak Pharma currently have 3 directors, including Ranjit Sundersing Advani, Deepa Haresh Advani, Haresh Ranjit Advani.